Do you want company information, newsletters and press releases sent directly to your email?
Please fill in your e-mail below to subscribe to news from Cereno Scientific AB.
Your e-mail (required)
By subscribing, you allow Cereno Scientific AB to send you information such as press releases, financial reports and newsletters.
Read more about how Cereno Scientific handles personal information here.
BioStock: FDA grants Cereno Scientific’s lead candidate Orphan Drug Designation
Cereno Scientific is accelerating the building of a platform of...
Cereno Scientific’s Phase II clinical trial postponed due to Covid-19
Due to the global spread of the Sars-cov-2 virus Cereno...
Cereno Scientific Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
Cereno Scientific today announced that the U.S. Food and Drug...
LSX World Congress
2020-02-04 - 2020-02-05
Subscribe for corporate news
Follow us on LinkedIn
Follow us on Twitter
We are proud supporters of World Thrombosis Day. Read more